[1] 丰有吉.卵巢癌初始治疗现状与挑战[J].中国实用妇科与产科杂志,2012,28(3):161-162.
[2] Cazzaniga M, Bonanni B. Relationship between metabolic reprogramming and mitochondrial activity in cancer cells. Understanding the anticancer effect of metformin and its clinical implications[J]. Anticancer Res,2015,35(11):5789-5796.
[3] Tseng CH. Metformin reduces gastric cancer risk in patients with type 2 diabetes mellitus[J]. Aging(Albany NY), 2016,8(8):1636-1649.
[4] Fujita K, Iwama H, Miyoshi H, et al. Diabetes mellitus and metformin in hepatocellular carcinoma[J]. World J Gastroenterol, 2016, 22(27):6100-6113.
[5] Febbraro T,Lengyel E,Romero IL. Old drug, new trick:repurposing metformin for gynecologic cancers [J]. Gynecol Oncol,2014,135(3):614-621.
[6] Poli G,Cantini G,Armignacco R, et al. Metformin as a new anti-cancer drug in adrenocortical carcinoma[J]. Oncotarget, 2016,7(31):49636-49648.
[7] Vallianou NG, Evangelopoulos A, Kazazis C. Metformin and cancer[J]. Rev Diabet Stud,2013,10(4):228-235.
[8] Lengyel E, Litchfield LM, Mitra AK, et al. Metformin inhibits ovarian cancer growth and increases sensitivity to paclitaxel in mouse models[J]. Am J Obstet Gynecol, 2015,212(4):479e1-479e10.
[9] Wu B, Li S, Sheng L, et al. Metformin inhibits the development and metastasis of ovarian cancer[J]. Oncol Rep, 2012,28(3):903-908.
[10] Tebbe C, Chhina J, Dar SA, et al. Metformin limits the adipocyte tumor-promoting effect on ovarian cancer[J]. Oncotarget,2014,5(13):4746-4764.
[11] Shank JJ, Yang K, Ghannam J, et al. Metformin targets ovarian cancer stem cells in vitro and in vivo[J]. Gynecol Oncol,2012,127(2):390-397.
[12] Bodmer M, Becker C, Meier C, et al. Use of metformin and the risk of ovarian cancer:a case-control analysis[J]. Gynecol Oncol,2011,123(2):200-204.
[13] Romero IL, McCormick A, McEwen KA, et al. Relationship of type Ⅱ diabetes and metformin use to ovarian cancer progression, survival,and chemosensitivity[J]. Obstet Gynecol, 2012,119(1):61-67.
[14] Kumar S, Meuter A, Thapa P, et al. Metformin intake is associated with better survival in ovarian cancer:a case-control study[J]. Cancer, 2013,119(3):555-562.
[15] Anisimov VN, Berstein LM, Egormin PA, et al. Effect of metformin on life span and on the development of spontaneous mammary tumors in HER-2/neu transgenic mice[J].Exp Gerontol,2005,40(8/9):685-693. |